ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

ASN / Education & Meetings / Kidney Week /

Translational Session

Mechanisms of Action for Kidney Protection with Novel Therapies for Diabetic Kidney Disease

October 26, 2024 | 02:00 PM - 04:00 PM

Location: Ballroom 20A, Convention Center

Session Description

This session addresses how SGLT2 inhibitors, nonsteroidal mineralocorticoid receptor antagonists, glucagon-like peptide 1 (GLP-1) receptor agonists, and other emerging therapies influence kidney health and disease. Studies of people with and without diabetes across a range of kidney risk are discussed.

Learning Objective(s)

  • Explain the mechanism of action for cardiovascular and kidney protection with SGLT2 inhibitors
  • Describe the mechanism of action for cardiovascular and kidney protection with nonsteroidal mineralocorticoid receptor antagonists
  • Specify the mechanism of action for cardiovascular and kidney protection with GLP-1 receptor agonists
  • Characterize the mechanism of action for cardiovascular and kidney protection with endothelin receptor antagonists
  • Interpret the implications for how to optimally combine new therapies for diabetic kidney disease based on the agents' mechanisms of action

Learning Pathway(s)

  • Diabetic Kidney Disease
  • Pharmacology

Moderators

Presentations